Comparative Analysis of Chemiluminescence Immunoassay ( CLIA )‐Based Tests in the Diagnosis of Invasive Aspergillosis in Patients With Hematologic Malignancies
Mycoses · 2025
DOI: 10.1111/myc.70064 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Mycoses, 2025. Verfasst von Esra Kılıç und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Microbiology, Gazi University Faculty of Medicine, Ankara, Turkiye. Hauptthemen laut MEDLINE: Hematologic Neoplasms, Luminescent Measurements, Aspergillosis, Invasive Fungal Infections. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: This study was funded by Gazi University Unit of Scientifc Research Projects (project no: TTU-2023-8627).
Abstract (Originalsprache)
Background and Aim Rapid chemiluminescence immunoassays (CLIA) have emerged as a promising alternative to traditional serological methods for the diagnosis of invasive aspergillosis (IA). The aim of this study was to compare the diagnostic performance of rapid CLIA tests in IA.
Methods
Patient group consisted of 17 patients who were diagnosed with probable IA according to EORTC/MSG criteria. Patients without invasive fungal infection (IFI) were defined as the control group, whereas healthy volunteers were also included. A total of 93 serum samples were used in this study. Platelia Aspergillus Ag test and Dynamiker Aspergillus Ag Kit, CLIA tests Aspergillus Galactomannan Detection Kit and Fungus (1–3) ꞵ‐D‐Glucan Detection Kit, were used. Specificity, sensitivity, negative predictive value (NPV), and positive predictive value (PPV) were calculated. Receiver operating characteristic (ROC) curve was used to evaluate the overall diagnostic performance of CLIA tests comparing FDA‐approved GM ELISA test.
Results
The sensitivity of the CLIA galactomannan (CLIA GM) test was 70.6%, specificity 92.1%, PPV 66.7% and NPV 93.3% ( p < 0.001), while the sensitivity of the CLIA beta‐glucan (CLIA BDG) test was 88.2%, specificity 81.6%, PPV 51.7% and NPV 96.9% ( p < 0.001). Using the PlateliaTM Aspergillus Ag Test as the reference method, the areas under the curve (AUC) of the ROC curve were 0.878 for CLIA BDG and 0.869 for CLIA GM.
Conclusions
CLIA‐based tests were evaluated as being rapid diagnostic tests for IA since their NPVs were found to be very high. Integrating CLIA into clinical practice may significantly improve diagnostic efficiency and patient outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Microbiology, Gazi University Faculty of Medicine, Ankara, Turkiye.
- Department of Infectious Diseases and Clinical Microbiology, Gazi University Faculty of Medicine, Ankara, Turkiye.
- Department of Hematology, Gazi University Faculty of Medicine, Ankara, Türkiye.
ORCID-Profile: Ayşe Kalkancı
Förderung
- This study was funded by Gazi University Unit of Scientifc Research Projects (project no: TTU-2023-8627)
Zitieren
APA
Kılıç, E., Şahin, E. A., Tunçcan, Ö. G., Yıldız, Ş., Özkurt, Z. N., Yeğin, Z. A., & Kalkancı, A. (2025). Comparative Analysis of Chemiluminescence Immunoassay ( CLIA )‐Based Tests in the Diagnosis of Invasive Aspergillosis in Patients With Hematologic Malignancies. Mycoses. https://doi.org/10.1111/myc.70064
Vancouver
Kılıç E, Şahin EA, Tunçcan ÖG, Yıldız Ş, Özkurt ZN, Yeğin ZA, et al. Comparative Analysis of Chemiluminescence Immunoassay ( CLIA )‐Based Tests in the Diagnosis of Invasive Aspergillosis in Patients With Hematologic Malignancies. Mycoses. 2025. doi:10.1111/myc.70064
BibTeX
@article{Kl2025,
author = {Kılıç, Esra and Şahin, Elif Ayça and Tunçcan, Özlem Güzel and Yıldız, Şeyma and Özkurt, Zübeyde Nur and Yeğin, Zeynep Arzu and Kalkancı, Ayşe},
title = {Comparative Analysis of Chemiluminescence Immunoassay ( CLIA )‐Based Tests in the Diagnosis of Invasive Aspergillosis in Patients With Hematologic Malignancies},
journal = {Mycoses},
year = {2025},
doi = {10.1111/myc.70064}
}
EUVIMED